Sonlicromanol
id:
sonlicromanol-301-13079006
title:
Sonlicromanol
text:
Sonlicromanol (KH176) is a clinical-stage oral drug compound developed by Khondrion as a potential treatment for inherited mitochondrial diseases, such as Leigh's Disease, MELAS and LHON. Due to dysfunctional mitochondria, an increased level of cellular reactive oxygen species (ROS) is observed in these patients, causing a wide range of symptoms. The active metabolite of Sonlicromanol has several mechanisms of action, acting both as antioxidant and as reactive oxygen species (ROS)-redox modulato
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Sonlicromanol
date created:
date modified:
2023-12-03T02:48:10Z
main entity:
{"identifier":"Q27896123","url":"https://www.wikidata.org/entity/Q27896123"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/c/c2/Sonlicromanol_and_metabolite.png","width":943,"height":658}
fields total:
13
integrity:
15